Imipramine reverses the depressive symptoms in sepsis survivor rats

Intensive Care Med. 2007 Dec;33(12):2165-7. doi: 10.1007/s00134-007-0804-y. Epub 2007 Aug 1.

Abstract

Objective: To evaluate the antidepressant effect of imipramine on depressive symptoms observed in sepsis survivors rats.

Design and setting: Prospective, controlled experiment in an animal basic science laboratory.

Subjects: Male Wistar rats weighing 300-350 g.

Interventions: The rats underwent cecal ligation and perforation (CLP; sepsis group) with "basic support" (saline at 50 ml/kg immediately and 12 h after CLP plus ceftriaxone at 30 mg/kg and clindamycin at 25 mg/kg 6, 12, and 18 h after CLP) or sham-operated (control group). After 10 days of recovery rats received intraperitoneal injections of imipramine 10 mg/kg or saline and were subjected to the forced swimming test.

Measurements and results: The observed increase in the immobility time in the forced swimming test in animals subjected to CLP, as a parameter of depressive behavior, was reversed by imipramine.

Conclusions: The depressive symptoms evaluated by forced swimming test had been reversed after imipramine administration. Our data provide evidence that CLP-induced depressive symptoms are sensitive to antidepressants.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antidepressive Agents, Tricyclic / administration & dosage
  • Antidepressive Agents, Tricyclic / pharmacology
  • Antidepressive Agents, Tricyclic / therapeutic use*
  • Brazil
  • Depression / drug therapy*
  • Depression / physiopathology
  • Imipramine / administration & dosage
  • Imipramine / pharmacology
  • Imipramine / therapeutic use*
  • Prospective Studies
  • Rats
  • Sepsis / psychology*
  • Treatment Outcome

Substances

  • Antidepressive Agents, Tricyclic
  • Imipramine